Doxycycline Pediatric Dose — Antimicrobial Dosing
Doxycycline is a second-generation tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. It is used in pediatric patients for a broad range of indications including atypical pneumonia, rickettsial diseases (e.g., Rocky Mountain spotted fever), Lyme disease, and other susceptible bacterial infections. Its availability in both intravenous and oral formulations makes it versatile in both inpatient and outpatient settings.
Pediatric Dosing
- 2.1 mg/kg per dose IV or PO every 12 hours
- Adult dose: 100 mg IV/PO every 12 hours (use adult dose once per-kg calculation exceeds 100 mg per dose)
Consult institutional protocol for weight-based maximum dose cap, as the adult ceiling of 100 mg per dose is typically applied once the calculated dose approaches that threshold.
Worked example — 20 kg child: 20 kg × 2.1 mg/kg = 42 mg per dose IV or PO every 12 hours. For a 50 kg adolescent: 50 × 2.1 mg/kg = 105 mg, which would be capped at the adult dose of 100 mg per dose.
Use with caution in children under 8 years of age due to the potential for permanent tooth discoloration and effects on bone growth associated with tetracycline-class agents. Notable exceptions include life-threatening rickettsial infections (e.g., Rocky Mountain spotted fever), where the benefit-risk profile strongly favors treatment regardless of age.
Indications and Clinical Context
Doxycycline is indicated for infections caused by susceptible organisms including Rickettsia spp., Anaplasma, Ehrlichia, Borrelia burgdorferi, atypical respiratory pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae), and select gram-negative bacteria. In pediatric emergency and critical care settings, it is a first-line agent for rickettsial diseases per CDC and PALS-aligned guidelines, where early empiric therapy is essential to prevent morbidity and mortality.
For community-acquired pneumonia with atypical coverage needs in older children and adolescents, doxycycline represents an appropriate oral step-down or outpatient option. Clinicians should confirm local susceptibility patterns and indication-specific treatment durations prior to prescribing.
Administration and Monitoring
Doxycycline may be administered intravenously or orally. IV infusions are typically given over 1–4 hours; consult institutional pharmacy guidelines for concentration and compatible diluents. Oral formulations should be taken with adequate fluid to reduce esophageal irritation; administration with food or milk may reduce GI adverse effects, though dairy can modestly reduce absorption. Avoid concurrent administration with antacids, calcium, iron, or magnesium-containing products.
- Key adverse effects to monitor: photosensitivity, GI upset (nausea, vomiting), esophageal irritation, and hepatotoxicity with prolonged use
- Caution in children < 8 years: risk of permanent dental staining and potential impact on bone development; use only when benefit clearly outweighs risk
- Contraindications: known hypersensitivity to tetracycline-class agents
- Consult institutional protocol for maximum single dose and total daily dose limits in pediatric patients
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.